€51.50
0.10% yesterday
Borsa Italiana, May 20, 05:35 pm CET
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Recordati Stock price

€51.50
+3.14 6.49% 1M
+1.05 2.08% 6M
+0.90 1.78% YTD
+1.15 2.28% 1Y
+8.94 21.01% 3Y
+9.94 23.92% 5Y
+31.96 163.56% 10Y
Borsa Italiana, Closing price Tue, May 20 2025
+0.05 0.10%
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Key metrics

Market capitalization €10.62b
Enterprise Value €12.65b
P/E (TTM) P/E ratio 25.41
EV/FCF (TTM) EV/FCF 23.17
EV/Sales (TTM) EV/Sales 5.24
P/S ratio (TTM) P/S ratio 4.40
P/B ratio (TTM) P/B ratio 5.36
Dividend yield 2.47%
Last dividend (FY24) €1.27
Revenue growth (TTM) Revenue growth 12.85%
Revenue (TTM) Revenue €2.41b
EBIT (operating result TTM) EBIT €665.36m
Free Cash Flow (TTM) Free Cash Flow €545.88m
Cash position €333.04m
EPS (TTM) EPS €2.00
P/E forward 20.72
P/S forward 4.04
EV/Sales forward 4.81
Show more

Is Recordati a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Recordati Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Recordati forecast:

5x Buy
45%
5x Hold
45%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a Recordati forecast:

Buy
45%
Hold
45%
Sell
9%

Financial data from Recordati

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,414 2,414
13% 13%
100%
- Direct Costs 770 770
12% 12%
32%
1,643 1,643
13% 13%
68%
- Selling and Administrative Expenses 501 501
9% 9%
21%
- Research and Development Expense 299 299
14% 14%
12%
843 843
16% 16%
35%
- Depreciation and Amortization 178 178
20% 20%
7%
EBIT (Operating Income) EBIT 665 665
15% 15%
28%
Net Profit 418 418
7% 7%
17%

In millions EUR.

Don't miss a Thing! We will send you all news about Recordati directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Recordati SpA engages in the research, development, manufacturing, and marketing of pharmaceuticals. It operates through the following segments: Specialty & Primary Care and Rare Diseases Pharmaceuticals. The Specialty & Primary Care segment is related to pharmaceutical chemicals business. The Rare Diseases Pharmaceuticals segment, which relates to the Rare Diseases treatment. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Head office Italy
CEO Robert Koremans
Employees 4,583
Founded 1996
Website www.recordati.it

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today